The Global Empty Capsules Market is Projected to Grow at a CAGR of 7.4% from 2018 to 2023. The empty capsules market is projected to reach USD 2.79 billion by 2023 from an estimated USD 1.95 billion in 2018, at a CAGR of 7.4%. The growing adoption of capsule formulations among the growing geriatric population, the growth of the pharmaceutical market along with the increasing R&D activities & clinical trials, and advancements in capsule delivery technologies are the major factors driving the market for empty capsules. Emerging markets (due to their low manufacturing costs) are expected to present significant opportunities for players. Other areas of opportunity are the development of halal gelatin capsules and the rising focus on sports nutrition. However, cultural practices and dietary restrictions are expected to restrain the growth of the empty capsules market.
The Non-gelatin Capsules Segment to Register the Highest CAGR During the Forecast Period. By type, the empty capsules market is segmented into gelatin and non-gelatin capsules.The gelatin capsules segment is further subsegmented into pig meat gelatin, bovine-derived gelatin, bone meal, and other gelatin sources.
The non-gelatin capsules segment is further divided into hydroxypropyl methylcellulose (HPMC) and pullulan & starch material. The non-gelatin capsules segment is expected to register the highest CAGR during the forecast period. This growth is largely driven by the increasing demand for non-animal-based products and the advantages offered by these capsules over gelatin-based ones, such as low hygroscopicity, physical stability, stability in different ranges of temperature & humidity, and low moisture content.
Immediate-release Capsules Are Projected to Register the Highest Growth Rate Between 2018 & 2023. By functionality, the empty capsules market is segmented into immediate-release, sustained-release, and delayed-release capsules.The immediate-release capsules segment is expected to witness the highest CAGR in the empty capsules market during the forecast period, owing to the widespread use of these capsules for the manufacture of antibiotics, antibacterials, antacids, painkillers, inhalators, cold and cough drug preparations, and dietary supplements.
Moreover, these capsules are the most commonly prescribed capsules to treat a wide range of diseases and disorders.
Dietary Supplements to Witness the Highest Growth Rate in the Forecast Period. By application, the empty capsules market is segmented into antibiotic & antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, antianemic preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold drugs, and other applications.The dietary supplements segment is expected to witness the highest CAGR during the forecast period.
Factors such as increased health awareness and rising affordability in emerging countries (such as India, China, and Brazil), increasing prevalence of lifestyle diseases, and increasing use of vitamin capsules due to their availability as over-the-counter (OTC) drugs are contributing to the growth of this segment.
Nutraceutical Industry to Be the Fastest-growing End-user Segment During the Forecast Period. Based on end user, the empty capsules market is segmented into the pharmaceutical industry, nutraceutical industry, cosmetic industry, and research laboratories.The nutraceutical industry segment is expected to witness the highest CAGR during the forecast period.
The rising demand for nutraceutical products to prevent the occurrence of lifestyle-associated diseases (such as obesity, arthritis, high blood pressure, cholesterol, and diabetes) is supporting the growth of this segment.
APAC to Witness the Highest Growth in the Empty Capsules Market During the Forecast Period. The empty capsules market in the APAC is expected to witness the highest CAGR during the forecast period. The presence of many global capsule manufacturers in China and India, growth in the pharmaceutical and nutraceutical industries, the relatively less stringent regulations in the nutraceutical industry in this region, an increasing focus on generics, and rising healthcare awareness are expected to drive the adoption of empty capsules in the Asia Pacific.
Break of primary participants was as mentioned below: • By Company Type: Tier 1: 48%, Tier 2: 34%, and Tier 3: 18% • By Designation: C-level: 42%, Director-level: 40%, and Others: 18% • By Region: North America: 38%, Europe: 25%, Asia Pacific: 30%, Latin America: 5%, and the Middle East & Africa: 2%
The prominent players in the global empty capsules market are Capsugel (US), ACG Worldwide (India), Qualicaps (Japan), Suheung Co. Ltd. (South Korea), CapsCanada Corporation (Canada), Qingdao Yiqing Medicinal Capsules Co., Ltd. (China), Shanxi Guangsheng Medicinal Capsules Co., Ltd. (China), Healthcaps India Ltd. (India), Snail Pharma Industry Co. Ltd. (China), Roxlor (US), Sunil Healthcare Ltd. (India), Medi-Caps Ltd. (India), Nectar Lifesciences Ltd. (India), Natural Capsules Ltd. (India), and Bright Pharma Caps Inc. (US).
Research Coverage The report analyzes the various empty capsule products and their adoption pattern.It aims at estimating the market size and future growth potential of the global empty capsules market for different segments—type, functionality, application, end user, and region.
The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one, or a combination of the below mentioned five strategies for strengthening their presence in the market.
This report provides insights on the following pointers: • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global empty capsules market • Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and product launches in the global empty capsules market • Market Development: Comprehensive information on the lucrative and emerging markets • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global empty capsules market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the global empty capsules market
Our reports have been used by over 10K customers, including:
The global pharmaceutical gelatin market is projected to reach USD 1.2 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 5.3% during the forecast period. Growth in this market is driven by the advantages of pharmaceutical gelatin such as utility and versatility in medical and biomedical applications, unique...
Drug Eluting Stents (DES) - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Drug Eluting Stents (DES)-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Drug Eluting Stents (DES) pipeline products with comparative analysis of...
Coronary Stents - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Coronary Stents - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Coronary Stents pipeline products with comparative analysis of the products at various stages...
PTA Balloon Catheters - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “PTA Balloon Catheters-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the PTA Balloon Catheters pipeline products with comparative analysis of the products...
The hydrocolloids market is projected to grow at a CAGR of 5.3%. The hydrocolloids market is estimated to be valued at USD 9.7 billion in 2020 and is projected to reach USD 12.6 billion by 2025, at a CAGR of 5.3% from 2020 to 2025. The growth of the hydrocolloids market is driven by factors such as the expansion of the processed food industry...
214 pages •
By Asia Market Information & Development Company
• Sep 2020
China’s demand for Anti-Tumor Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...
The Asia Pacific liposome drug delivery market is expected to reach US$ 1,562.92 million in 2027 from US$ 759.81 in 2019. The market is estimated to grow with a CAGR of 9.6% from 2020-2027. The growth of the market is attributed to the some key driving factors such as high incidence of chronic diseases amongst the population, an upsurge...
Calcitonin Gene Related Peptide Type 1 Receptor - Pipeline Review, H2 2020 Summary Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) - Calcitonin receptor-like (CALCRL) also known as the calcitonin receptor-like receptor (CRLR) is a G protein-coupled receptor....